아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

hope pharmaceuticals ltd - sodium thiosulfate - solution for injection - 250 milligram(s)/millilitre - antidotes; thiosulfate

이스라엘 - 영어 - Ministry of Health

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 0.5 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

이스라엘 - 영어 - Ministry of Health

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 1 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

이스라엘 - 영어 - Ministry of Health

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 3 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

이스라엘 - 영어 - Ministry of Health

astellas pharma international b.v., israel - tacrolimus as monohydrate - capsules prolonged release - tacrolimus as monohydrate 5 mg - tacrolimus - prophylaxis of transplant rejection in adult kidney or liver allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult kidney or liver allograft recipient patients.

이스라엘 - 영어 - Ministry of Health

rafa laboratories ltd - netupitant; palonosetron as hydrochloride - capsules - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

이스라엘 - 영어 - Ministry of Health

rafa laboratories ltd - chlormethine as hydrochloride - gel - chlormethine as hydrochloride 160 mcg/g - chlormethine - topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin-directed therapy

이스라엘 - 영어 - Ministry of Health

medison pharma ltd - sapropterin dihydrochloride - tablets soluble - sapropterin dihydrochloride 100 mg - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

이스라엘 - 영어 - Ministry of Health

medison pharma ltd - sapropterin dihydrochloride - tablets soluble - sapropterin dihydrochloride 100 mg - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

미국 - 영어 - NLM (National Library of Medicine)

rebel distributors corp - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor